Alzheimer disease

An in-depth report on the causes, diagnosis, and treatment of Alzheimer disease.

I Would Like to Learn About:

Related Reports

References

AGS Choosing Wisely Workgroup. American Geriatrics Society identifies another five things that healthcare providers and patients should question. J Am Geriatr Soc. 2014;62(5):950-960. PMID: 24575770 pubmed.ncbi.nlm.nih.gov/24575770/.

AGS Choosing Wisely Workgroup. American Geriatrics Society identifies five things that healthcare providers and patients should question. J Am Geriatr Soc. 2013;61(4):622-631. PMID: 23469880 pubmed.ncbi.nlm.nih.gov/23469880/.

Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011;7(3):270-279. PMID: 21514249 pubmed.ncbi.nlm.nih.gov/21514249/.

Alzheimer's Association website. 2018 Alzheimer's disease facts and figures. Alzheimers Dement. 2018;14(3):367-429. www.alz.org/media/HomeOffice/Facts%20and%20Figures/facts-and-figures.pdf.

Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. JAMA. 2019;322(16):1589-1599. PMID: 31638686 pubmed.ncbi.nlm.nih.gov/31638686/.

Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386(10004):1672-1682. PMID: 26595641 pubmed.ncbi.nlm.nih.gov/26595641/.

Birks JS1, Grimley Evans J. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. 2015;(4):CD001191. PMID: 25858345 pubmed.ncbi.nlm.nih.gov/25858345/.

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev. 2016;4:CD009002. PMID: 27063583 pubmed.ncbi.nlm.nih.gov/27063583/.

Creavin ST, Wisniewski S, Noel-Storr AH, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;(1):CD011145. PMID: 26760674 pubmed.ncbi.nlm.nih.gov/26760674/.

Dubois B, Hampel H, Feldman HH, et al. Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on "The Preclinical State of AD"; July 23, 2015; Washington DC, USA. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292-323. PMID: 27012484 pubmed.ncbi.nlm.nih.gov/27012484/.

Hampel H, O'Bryant SE, Molinuevo JL, et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol. 2018;14(11):639-652. PMID: 30297701 pubmed.ncbi.nlm.nih.gov/30297701/.

Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011;7(3):257-262. PMID: 21514247 pubmed.ncbi.nlm.nih.gov/21514247/.

Knopman DS. Cognitive impairment and dementia. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier Saunders; 2020:chap 374.

Martínez G, Vernooij RW, Fuentes Padilla P, Zamora J, Bonfill Cosp X, Flicker L. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2017;11:CD012216. PMID: 29164603 pubmed.ncbi.nlm.nih.gov/29164603/.

McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;(1):CD003160. PMID: 26727124 pubmed.ncbi.nlm.nih.gov/26727124/.

McGuinness B, Craig D, Bullock R, Malouf R, Passmore P. Statins for the treatment of dementia. Cochrane Database Syst Rev. 2014;(7):CD007514. PMID: 25004278 pubmed.ncbi.nlm.nih.gov/25004278/.

McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011;7(3):263-269. PMID: 21514250 pubmed.ncbi.nlm.nih.gov/21514250/.

Mendez MF. Early-onset Alzheimer disease. Neurol Clin. 2017;35(2):263-281. PMID: 28410659 pubmed.ncbi.nlm.nih.gov/28410659/.

Mitchell SL. CLINICAL PRACTICE. Advanced dementia. N Engl J Med. 2015;372(26):2533-2540. PMID: 26107053 pubmed.ncbi.nlm.nih.gov/26107053/.

Molinuevo JL, Ayton S, Batrla R, et al. Current state of Alzheimer's fluid biomarkers. Acta Neuropathol. 2018;136(6):821-853. PMID: 30488277 pubmed.ncbi.nlm.nih.gov/30488277/.

Olivari BS, Baumgart M, Lock SL, et al. CDC grand rounds: promoting well-being and independence in older adults. MMWR Morb Mortal Wkly Rep. 2018;67(37):1036-1039. PMID: 30235185 pubmed.ncbi.nlm.nih.gov/30235185/.

Peterson R, Graff-Radford J. Alzheimer disease and other dementias. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 95.

Rosenberg RN, Lambracht-Washington D, Yu G, Xia W. Genomics of Alzheimer disease: a review. JAMA Neurol. 2016;73(7):867-874. PMID: 27135718 pubmed.ncbi.nlm.nih.gov/27135718/.

Sharma K. Cholinesterase inhibitors as Alzheimer's therapeutics (Review). Mol Med Rep. 2019;20(2):1479-1487. PMID: 31257471 pubmed.ncbi.nlm.nih.gov/31257471/.

BACK TO TOP

Review Date: 3/29/2021  

Reviewed By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2021 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.